Concepedia

Publication | Open Access

Dupilumab significantly improves skin barrier function in patients with moderate‐to‐severe atopic dermatitis

99

Citations

20

References

2022

Year

Abstract

Inhibition of IL-4/IL-13 signaling by dupilumab allows restoration of skin lipid composition and barrier function in patients with moderate-to-severe AD.

References

YearCitations

Page 1